Sofosbuvir/Ledipasvir Compound Drugs Market
1 Study Coverage
1.1 Sofosbuvir/Ledipasvir Compound Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Sofosbuvir/Ledipasvir Compound Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Market by Application
1.3.1 Global Sofosbuvir/Ledipasvir Compound Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hepatitis C Virus (HCV) Genotype 1
1.3.3 Hepatitis C Virus (HCV) Genotype 3
1.3.4 Hepatitis C Virus (HCV) Genotype 4
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Region
2.4.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Sofosbuvir/Ledipasvir Compound Drugs by Region (2023-2028)
2.5 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region
2.5.1 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2017-2022)
2.5.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Manufacturers
3.1.1 Global Top Sofosbuvir/Ledipasvir Compound Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sofosbuvir/Ledipasvir Compound Drugs in 2021
3.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Manufacturers
3.2.1 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sofosbuvir/Ledipasvir Compound Drugs Revenue in 2021
3.3 Global Sofosbuvir/Ledipasvir Compound Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sofosbuvir/Ledipasvir Compound Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sofosbuvir/Ledipasvir Compound Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type
4.1.1 Global Sofosbuvir/Ledipasvir Compound Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Sofosbuvir/Ledipasvir Compound Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
4.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type
4.2.1 Global Sofosbuvir/Ledipasvir Compound Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Sofosbuvir/Ledipasvir Compound Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type
4.3.1 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2017-2022)
4.3.2 Global Sofosbuvir/Ledipasvir Compound Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application
5.1.1 Global Sofosbuvir/Ledipasvir Compound Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Sofosbuvir/Ledipasvir Compound Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
5.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application
5.2.1 Global Sofosbuvir/Ledipasvir Compound Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Sofosbuvir/Ledipasvir Compound Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application
5.3.1 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2017-2022)
5.3.2 Global Sofosbuvir/Ledipasvir Compound Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Type
6.1.1 North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028)
6.1.2 North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2028)
6.2 North America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Application
6.2.1 North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028)
6.2.2 North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2028)
6.3 North America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
6.3.1 North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2028)
6.3.2 North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Sofosbuvir/Ledipasvir Compound Drugs Market Size by Type
7.1.1 Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028)
7.1.2 Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2028)
7.2 Europe Sofosbuvir/Ledipasvir Compound Drugs Market Size by Application
7.2.1 Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028)
7.2.2 Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2028)
7.3 Europe Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
7.3.1 Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2028)
7.3.2 Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Market Size by Type
8.1.1 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Market Size by Application
8.2.1 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Market Size by Region
8.3.1 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Type
9.1.1 Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028)
9.1.2 Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2028)
9.2 Latin America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Application
9.2.1 Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028)
9.2.2 Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2028)
9.3 Latin America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
9.3.1 Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2028)
9.3.2 Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Market Size by Type
10.1.1 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Market Size by Application
10.2.1 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
10.3.1 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Overview
11.1.3 Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Gilead Sciences Recent Developments
11.2 Natco Ltd
11.2.1 Natco Ltd Corporation Information
11.2.2 Natco Ltd Overview
11.2.3 Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Natco Ltd Recent Developments
11.3 Zydus Cadila
11.3.1 Zydus Cadila Corporation Information
11.3.2 Zydus Cadila Overview
11.3.3 Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zydus Cadila Recent Developments
11.4 Hetero Drugs
11.4.1 Hetero Drugs Corporation Information
11.4.2 Hetero Drugs Overview
11.4.3 Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hetero Drugs Recent Developments
11.5 Dr Reddy's Laboratories
11.5.1 Dr Reddy's Laboratories Corporation Information
11.5.2 Dr Reddy's Laboratories Overview
11.5.3 Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr Reddy's Laboratories Recent Developments
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Corporation Information
11.6.2 Sun Pharmaceutical Industries Overview
11.6.3 Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharmaceutical Industries Recent Developments
11.7 Cipla
11.7.1 Cipla Corporation Information
11.7.2 Cipla Overview
11.7.3 Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cipla Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Overview
11.8.3 Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Abbott Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Abbott Recent Developments
11.9 Biocon
11.9.1 Biocon Corporation Information
11.9.2 Biocon Overview
11.9.3 Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Biocon Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biocon Recent Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Corporation Information
11.10.2 Torrent Pharmaceuticals Overview
11.10.3 Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Torrent Pharmaceuticals Recent Developments
11.11 Lupin Ltd
11.11.1 Lupin Ltd Corporation Information
11.11.2 Lupin Ltd Overview
11.11.3 Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Lupin Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sofosbuvir/Ledipasvir Compound Drugs Industry Chain Analysis
12.2 Sofosbuvir/Ledipasvir Compound Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sofosbuvir/Ledipasvir Compound Drugs Production Mode & Process
12.4 Sofosbuvir/Ledipasvir Compound Drugs Sales and Marketing
12.4.1 Sofosbuvir/Ledipasvir Compound Drugs Sales Channels
12.4.2 Sofosbuvir/Ledipasvir Compound Drugs Distributors
12.5 Sofosbuvir/Ledipasvir Compound Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sofosbuvir/Ledipasvir Compound Drugs Industry Trends
13.2 Sofosbuvir/Ledipasvir Compound Drugs Market Drivers
13.3 Sofosbuvir/Ledipasvir Compound Drugs Market Challenges
13.4 Sofosbuvir/Ledipasvir Compound Drugs Market Restraints
14 Key Findings in The Global Sofosbuvir/Ledipasvir Compound Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Sofosbuvir/Ledipasvir Compound Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Bottled Packaging
Table 3. Major Manufacturers of Film Coated Packaging
Table 4. Global Sofosbuvir/Ledipasvir Compound Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Sofosbuvir/Ledipasvir Compound Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 19. Global Sofosbuvir/Ledipasvir Compound Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Sofosbuvir/Ledipasvir Compound Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sofosbuvir/Ledipasvir Compound Drugs as of 2021)
Table 21. Sofosbuvir/Ledipasvir Compound Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Sofosbuvir/Ledipasvir Compound Drugs Product Offered
Table 23. Date of Manufacturers Enter into Sofosbuvir/Ledipasvir Compound Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Type (2017-2022)
Table 28. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Type (2023-2028)
Table 29. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Type (2017-2022)
Table 32. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Type (2023-2028)
Table 33. Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 34. Global Sofosbuvir/Ledipasvir Compound Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 35. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2022) & (K Pcs)
Table 36. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2023-2028) & (K Pcs)
Table 37. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Application (2017-2022)
Table 38. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Application (2023-2028)
Table 39. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Application (2017-2022)
Table 42. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Application (2023-2028)
Table 43. Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 44. Global Sofosbuvir/Ledipasvir Compound Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 45. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2022) & (K Pcs)
Table 50. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2023-2028) & (K Pcs)
Table 51. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2022) & (K Pcs)
Table 62. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2023-2028) & (K Pcs)
Table 63. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2022) & (K Pcs)
Table 74. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2023-2028) & (K Pcs)
Table 75. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2022) & (K Pcs)
Table 86. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2023-2028) & (K Pcs)
Table 87. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Gilead Sciences Corporation Information
Table 106. Gilead Sciences Description and Major Businesses
Table 107. Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 108. Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Gilead Sciences Recent Developments
Table 110. Natco Ltd Corporation Information
Table 111. Natco Ltd Description and Major Businesses
Table 112. Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Natco Ltd Recent Developments
Table 115. Zydus Cadila Corporation Information
Table 116. Zydus Cadila Description and Major Businesses
Table 117. Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Zydus Cadila Recent Developments
Table 120. Hetero Drugs Corporation Information
Table 121. Hetero Drugs Description and Major Businesses
Table 122. Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Hetero Drugs Recent Developments
Table 125. Dr Reddy's Laboratories Corporation Information
Table 126. Dr Reddy's Laboratories Description and Major Businesses
Table 127. Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Dr Reddy's Laboratories Recent Developments
Table 130. Sun Pharmaceutical Industries Corporation Information
Table 131. Sun Pharmaceutical Industries Description and Major Businesses
Table 132. Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sun Pharmaceutical Industries Recent Developments
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Major Businesses
Table 137. Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. Cipla Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Cipla Recent Developments
Table 140. Abbott Corporation Information
Table 141. Abbott Description and Major Businesses
Table 142. Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. Abbott Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Abbott Recent Developments
Table 145. Biocon Corporation Information
Table 146. Biocon Description and Major Businesses
Table 147. Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Biocon Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Biocon Recent Developments
Table 150. Torrent Pharmaceuticals Corporation Information
Table 151. Torrent Pharmaceuticals Description and Major Businesses
Table 152. Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Torrent Pharmaceuticals Recent Developments
Table 155. Lupin Ltd Corporation Information
Table 156. Lupin Ltd Description and Major Businesses
Table 157. Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 158. Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Lupin Ltd Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Sofosbuvir/Ledipasvir Compound Drugs Distributors List
Table 163. Sofosbuvir/Ledipasvir Compound Drugs Customers List
Table 164. Sofosbuvir/Ledipasvir Compound Drugs Market Trends
Table 165. Sofosbuvir/Ledipasvir Compound Drugs Market Drivers
Table 166. Sofosbuvir/Ledipasvir Compound Drugs Market Challenges
Table 167. Sofosbuvir/Ledipasvir Compound Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Sofosbuvir/Ledipasvir Compound Drugs Product Picture
Figure 3. Global Sofosbuvir/Ledipasvir Compound Drugs Market Share by Type in 2021 & 2028
Figure 3. Bottled Packaging Product Picture
Figure 4. Film Coated Packaging Product Picture
Figure 5. Global Sofosbuvir/Ledipasvir Compound Drugs Market Share by Application in 2021 & 2028
Figure 6. Hepatitis C Virus (HCV) Genotype 1
Figure 7. Hepatitis C Virus (HCV) Genotype 3
Figure 8. Hepatitis C Virus (HCV) Genotype 4
Figure 9. Other
Figure 10. Sofosbuvir/Ledipasvir Compound Drugs Report Years Considered
Figure 11. Global Sofosbuvir/Ledipasvir Compound Drugs Sales 2017-2028 (K Pcs)
Figure 12. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America Sofosbuvir/Ledipasvir Compound Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 18. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 20. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 22. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 24. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 26. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Sofosbuvir/Ledipasvir Compound Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Sofosbuvir/Ledipasvir Compound Drugs in the World: Market Share by Sofosbuvir/Ledipasvir Compound Drugs Revenue in 2021
Figure 29. Global Sofosbuvir/Ledipasvir Compound Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Country (2017-2028)
Figure 39. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Country (2017-2028)
Figure 40. U.S. Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Region (2017-2028)
Figure 59. China Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
Figure 70. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
Figure 72. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Country (2017-2028)
Figure 74. Latin America Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Country (2017-2028)
Figure 75. Mexico Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue Share by Country (2017-2028)
Figure 84. Turkey Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Sofosbuvir/Ledipasvir Compound Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Sofosbuvir/Ledipasvir Compound Drugs Value Chain
Figure 88. Sofosbuvir/Ledipasvir Compound Drugs Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
